Summary Up-regulation of autocrine motility factor receptor (AMF-R) expression has been shown to be associated with invasion and metastasis of experimental tumour systems and human neoplasms. Monoclonal antibodies against AMF-R (gp78) were used to stain 221 primary gastric cancer specimens, and level of expression was examined in relation to pathological stage and prognostic values. In 125 out of 221 (56.6%) patients, gp78 was detected. Expression of gp78 was associated with macroscopic type, lymphatic and venous invasions, and lymph node and peritoneal metastasis. The level of gp78 expression in the cancer specimens was associated with histopathological stage and grade of tumour penetration. Positive gp78 expression was significantly associated with poor prognosis (P<0.001). This significant relationship remained among patients in stages II and III. The results suggest that gp78 expression could be used as a prognostic marker in gastric cancer patients.
The incidence of gastric carcinoma is the highest of all carcinomas, and it is the leading cause of death from cancer in Japan. In spite of the improvement in surgical treatment and chemotherapy, the prognosis in this disease is still poor owing to local recurrence or metastasis (Baba et al., Bonenkamp et al., 1995; Hallissey et al., 1994; Nakazato et al., 1994) .
Many investigators study the mechanism of tumour cell invasion and metastasis to better understand local recurrence and metastasis (Nekarda et al., 1994; Nomura et al., 1995; Sato et al., 1994; Yonemura et al., 1995) . Among the various steps of invasion or metastasis of the cancer cell, cell motility is one of the important factors that promotes cancer progression (Fidler, 1990; Hart et al., 1989; Liotta et al., 1986; Nabi et al., 1991) . However, the relationship between gastric cancer stages and cell motility-regulated factors has not been reported. Thus, it is of obvious interest to study such parameters in order to obtain an insight into the biological behaviour of gastric cancers.
Autocrine motility factor (AMF) is a cytokine that is produced and secreted by cancer cells and that stimulates both random and directed cell migration through binding to its receptor, a 78 kDa cell surface glycoprotein (gp78, AMF receptor) (Liotta et al., 1986; Nabi et al., 1990 Nabi et al., , 1991 Silletti et al., 1991) . Recently, a molecular cloning of AMF receptor (AMF-R) was reported (Watanabe et al., 1991a) . Expression of this receptor relates to cell motility-regulating effects and also may play an important role in tumour cell invasion or metastasis (Nabi et al., 1992; Watanabe et al., 1991b) . Recent studies have demonstrated that increased expression of gp78 is correlated with a high incidence of recurrence and decreased survival of patients with colorectal cancer, bladder cancer and oesophageal cancer (Nakamori et al., 1994; Otto et al., 1994; Maruyama et al., 1995) .
Here, we studied the expression of gp78 in specimens from 221 patients with primary gastric cancers. A possible relationship between gp78 expression, clinicopathological features and survival rates was examined in order to establish the usage of this antigen for prognosis in human primary gastric carcinoma.
Materials and Methods

Patients
Two hundred and twenty-one patients with primary gastric cancer, who were diagnosed and treated at the Department of Surgery II, Kanazawa University, from 1986 to 1991, were evaluated retrospectively. All patients had undergone total or subtotal gastrectomy combined with extensive lymph node dissection. Throughout this report, the Japanese Classification of Gastric Carcinoma by the Japanese Research Society for Gastric Cancer was used for the description and classification of variables. (Dako, Glostrup, Denmark) in PBS for 20 min at room temperature to block non-specific binding of the second antibody. After blocking against endogenous avidin and biotin, sections were incubated with anti-gp78 monoclonal antibody, 3F3A (Nabi et al., 1990; Silletti et al., 1991; Nakamori et al., 1994; Otto et al., 1994; Maruyama et al., 1995) , at a dilution of 1:200 in PBS containing 1% bovine serum albumin (Sigma, St. Louis, MO, USA) overnight at 4°C. After three rinses in PBS, sections were incubated with biotinylated anti-rat immunoglobulin (Dako) for 1 h at room temperature, washed three times with PBS and reacted with streptoavidin-biotin system Correspondence: Y Hirono, Department of Surgery, Keiju General Hospital, Tomioka-cho 94, Nanao, Ishikawa, 926, Japan Received 5 January 1996; revised 7 June 1996; accepted 1 July 1996 (Dako), using 0.04% 3,3'-diaminobenzide tetrahydrochloride (Sigma) for 1 min as chromogen. Sections were lightly counterstained in methyl green. Positive controls were prepared using sections from formalin-fixed, paraffinembedded malignant melanoma. Negative controls were prepared by substituting normal rat serum for the primary antibody, which resulted in no staining.
The degree of monoclonal antibody reactivity with each tissue sections was considered positive if unequivocal staining of membrane or cytoplasm was seen in more than 10% of tumour cells as described previously (Otto et al., 1994; Maruyama et al., 1995) . All sections were analysed blind without knowledge of the patient's treatment outcome or clinicopathological findings.
Statistical analysis Statistical analyses were performed using the chi-square test. Survival rate was calculated by the Kaplan-Meier method. The outcomes of different groups of patients were compared using the generalised Wilcoxon test. Using the Cox's proportional hazard model, multivariate regression analysis of survival data was performed (Cox, 1972) . The difference was considered to be significant when P was less than 0.05.
Results
A total of 221 gastric cancer specimens were stained for gp78 expression. There were 125 (56.6%) carcinomas positive for gp78 expression. In tumour tissues, both cell membrane and cytoplasm were immunohistochemically stained heterogeneously ( Figure 1 a and b) . Weak staining of normal mucosa, mainly in the proliferative zone, was also noticed in some of the sections (Figure lc) . Tumour cells stained intensively were more often found in the invasive peripheral region than in the central region of the tumour (Figure 2a and b). There was no significant association between the gp78 expression and tumour size or histological type (Table I) AMF receptor in gastric cancer Y Hirono et al x 2005 significant difference between these four groups of patients (P=0.0018). The gp78 expression was also correlated with both lymphatic invasion (P= 0.0020) and venous invasion (P=0.0075). The nodal status was such that gp78 staining was found in 24 (40.0%) of 60 tumours without lymph node involvement, and 101 (62.7%) of 161 tumours with lymph node metastasis; there was a good correlation between these two groups of tumours (P=0.0040). However, there was no significant relationship between liver metastasis and gp78 expression. Eighty-seven (50.3%) of 173 tumours without peritoneal dissemination were gp78 expression negative, whereas 38 (79.8%) of 48 tumours with peritoneal dissemination were positively stained for gp78; the difference was statistically significant (P= 0.0007). In all of the examined cases, the patients with gp78 expression-positive carcinomas had poorer prognoses than did the expressionnegative patients. The 5 year survival rates of the gp78 expression-positive group and the expression-negative group were 37.5% and 63.8% respectively (Figure 3 ). There was a significant advantage in survival for the gp78 expressionnegative group (P<0.001). Even when the patients who belonged to early stage (stage I) or highly advanced stage (stage IV) were excluded, the patients with gp78 expressionpositive tumours had a significantly poorer prognosis than those with expression-negative tumours (P<0.05) (Figure 4 ). In these groups (stages II and III), the 5 year survival rates of the gp78 expression-positive group and the expressionnegative group were 59.3% and 75.3% respectively. In the same group, the univariate analysis revealed no correlation between prognosis and the other clinicopathological factors, such as age, sex, tumour size, histological type, macroscopic type, lymph node metastasis, serosal invasion, lymphatic invasion and venous invasion (Table II) . Multivariate analysis also revealed that only gp78 expression was an independent prognostic factor in all the clinicopathological factors mentioned above (P=0.0388).
Discussion
Cell motility plays an important role in embryonic tissue remodelling, wound healing, angiogenesis, immune defence, invasion and metastasis. Cell locomotion is reported to be affected by a variety of agents, including host-derived scatter factor (Weidner et al., 1991) , extracellular matrix components (Turley et al., 1991) and various of the growth factors, such as platelet-derived growth factor (Seppa et al., 1982) , fibroblast growth factor (Sato and Rifkin, 1988) , insulin-like growth factor (Stracke et al., 1989 ) and transforming growth factor-fl (Mooradian et al., 1992) . In normal physiological status, motility is tightly regulated, whereas tumour cell motility may be aberrantly regulated or autoregulated. Tumour-secreted or autocrine factors, like AMF or autotaxin, may be involved in this autoregulation (Liotta et al., 1986; Stracke et al., 1992) . AMF receptor is also engaged in tumour cell motility (Nabi et al., , 1992 Watanabe et al., 1991a) . These studies mainly focus on the motility of fibrosarcoma (Watanabe et al., 1991a; Watanabe et al., 1994) , fibroblast (Silletti and Raz, 1993) and melanoma cells (Liotta et al., 1986; Silletti et al., 1991; Stracke et al., 1992) .
A previous study reported the significant correlation between gp78 expression and histological differentiation in colorectal carcinoma (Nakamori et al., 1994) . Here, we could not find a significant relationship between gp78 expression and histological differentiation in primary gastric carcinoma. However, patients with undifferentiated type carcinomas had higher positive rates of gp78 expression than patients with differentiated type tumours. Correlation between cell motility and cell differentiation is still unclear in gastric cancer. We found that AMF-R expression was significantly correlated with lymph node metastasis, extent of invasion and lymphatic/venous invasion in primary gastric cancer, similar to colorectal, oesophageal and bladder carcinomas. Furthermore, we found a new significant relationship between gp78 (Adachi et al., 1994; Yonemura et al., 1991a,b; Aretxabala et al., 1987) . We think the Japanesetype extended lymphadenectomy might have an influence on this result.
Patients in stage I have favourable prognoses with adequate surgical treatments and mild chemotherapies (Baba et al., 1995) . Patients with stage II and III gastric cancer can have hope that the disease could be cured with completely extended radical dissection and adequate chemotherapy (Maehara 1994; Nakazato et al., 1994) . In contrast, the prognoses of the patients in stage IV are poor, in spite of extended surgical treatments and intensive chemotherapies. Therefore, an analysis of gp78 expression may provide additional guidance regarding post-operative prognosis and the need for a chemotherapy regimen for each patient. Furthermore, we previously reported the preoperative evaluation of oncogene expression by reverse transcription polymerase chain reaction (RT-PCR) with endoscopic biopsy specimen for the assessment of malignant potential (Ninomiya et al., 1992) . It is suggested that if gp78 expression is assessed by an endoscopic biopsy specimen before operation, one may obtain an indication of the extent of the tumour resection and the need for lymph node dissection. We have demonstrated the use of continuous hyperthermic peritoneal perfusion (CHPP) for therapy against peritoneal dissemination in gastric cancer (Fujimura et al., 1990) . With an analysis of gp78 expression, CHPP could be carried out only on the high-risk group.
Normal gastric mucosa, especially in the proliferative zone, was positively stained with anti-gp78 antibody, but more weakly than tumour cells in gastric cancer. In previous studies, both normal colorectal mucosa and urothelial and oesophageal epithelia were negatively stained for gp78 (Nakamori et al., 1994; Otto et al., 1994) . AMF stimulates motility of fibroblasts via its receptor, which might play an important role in wound healing (Silletti and Raz, 1993) . Because gastric mucosa turns over rapidly, AMF receptor might be involved in the migration of epithelial cells. Further investigation is necessary to clarify the role of AMF and its receptor in cellular migration within gastric mucosal grand.
We may conclude that the expression of AMF receptor plays an important role in both the invasion and the metastasis of gastric cancer cells and is involved in the prognoses of patients with gastric cancer. An analysis of AMF receptor may be useful in predicting the clinical outcome and deciding the therapeutic schedule of patients with carcinoma of the stomach. Abbreviations AMF, autocrine motility factor; AMF-R, AMF receptor; PBS, phosphate-buffered saline; m, mucosa; sm, submucosa; mp, muscularis propria; ss, subserosa; se, serosa-exposed; si, serosainfiltrating; gp78, 78 kDa cell surface glycoprotein; RT-PCR, reverse transcription-polymerase chain reaction.
